{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-189691","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2025-08-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.497079+00:00","generated_at":"2026-05-17T09:38:02.263607+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Enanta designates interim CFO and principal accounting officer during CFO medical leave","bullets":["Harry Trout (VP Finance) named interim principal financial officer; Katie Capps (Executive Director, Accounting) interim principal accounting officer.","Appointments effective Aug 26, 2025, while CFO Paul Mellett is on a medical leave of absence.","Trout joined Enanta in 2002; Capps joined in 2016; both have held increasing finance roles.","Neither interim officer has entered into new material plans or arrangements in connection with this appointment."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-189691","json":"https://secwatch.observer/filing/0001193125-25-189691.json","markdown":"https://secwatch.observer/filing/0001193125-25-189691.md","text":"https://secwatch.observer/filing/0001193125-25-189691.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000119312525189691/0001193125-25-189691-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000119312525189691/enta-20250826.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T09:38:02.263607+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}